Home
Products
COVID-19 POCT
Antigen Rapid Test
VOC-based POCT
Women's Health
Pneumonia
Ainos Pen
AI Nose
Technology
AI Nose
Low-dose interferon
Synthetic RNA
Support
About Us
News
Investors
English
繁體中文
日本語
News Releases
Search by year or by keyword :
Search
Date
Title
2020-12-30
Amarillo Biosciences, Inc. Enters into a Securities Purchase Agreement to Foster New Growth.
2020-09-10
Amarillo Biosciences to Initiate Low-Dose Interferon Clinical Trials to Treat COVID-19, Appoints Interferon Specialist Dr. Manfred Beilharz to Scientific Advisory Board.
2020-08-13
Amarillo Biosciences to Reaffirm Low-Dose Interferon Research Leadership Position and Global Commitment to Support Related Therapeutics.
2020-02-13
Amarillo Biosciences to Explore Low-Dose Oral Interferon Therapeutics in China as a Line of Defense Against Coronavirus and Other Viral Indications.
2019-07-29
Amarillo Biosciences and Xiamen Weiyang Pharmaceutical Sign Term Sheet Outlining China Licensing and Royalty Agreement
2018-08-23
Amarillo Biosciences First-Half 2018 Business Update.
2017-09-06
Amarillo Biosciences, Inc. Announces Investor Update (Sept 6, 2017)
2015-05-18
Amarillo Biosciences, Inc. Summarizes New Plan of Operation.
2015-02-02
Amarillo Biosciences, Inc. Reorganizes, Exits Bankruptcy, and Opens a New Chapter in the Healthcare Industry.
«
1
2
3
4
5
»
CONTACT US
United States:
8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108
+1 (858) 869-2986
Taiwan:
10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.)
+886 (0)3-550-5199
COMPANY
Products
AI Nose
Low-Dose Oral Interferon
Synthetic RNA
News
Privacy policy
INVESTORS
Overview
Stock Info
IR News
Governance
Financials
Alerts
OUR AGENTS
INABATA & CO., LTD.
TAIWAN ORIACT CO., LTD.
Copyright © 2023 Ainos Inc. All rights reserved.